NCT02829775
- Conditions
- Adenocarcinoma, Bone Marrow Diseases, Carcinoma, +36 more
- Locations
-
- Sofia, Bulgaria
- Halifax, Nova Scotia, Canada
- Lucknow, India
- Moscow, Russia
Clinical trial condition
Neuroectodermal Tumors
Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.
6,008 public trials
1,220 recruiting studies
Neuroectodermal Tumors trial results
NCT01974752
- Conditions
- Eye Diseases, Eye Neoplasms, Melanoma, +16 more
- Locations
-
- Research Site Los Angeles, California, United States
- Research Site Aurora, Colorado, United States
- Research Site Atlanta, Georgia, United States
- Research Site Lutherville, Maryland, United States
NCT00085540
- Conditions
- Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +21 more
- Locations
-
- University of California Los Angeles Los Angeles, California, United States
- University of California San Francisco San Francisco, California, United States
- National Cancer Institute Neuro-Oncology Branch Bethesda, Maryland, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT00109005
- Conditions
- Eye Diseases, Eye Neoplasms, Melanoma, +14 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
NCT00777153
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +8 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Pheonix, Arizona, United States
- Research Site Los Angeles, California, United States
- Research Site New Haven, Connecticut, United States
NCT01477463
- Conditions
- Melanoma, Melanoma, Skin, Neoplasms, +10 more
- Locations
-
- Stanford University Cancer Institute Palo Alto, California, United States
Completed
IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma
NCT01189383
- Conditions
- Malignant Melanoma Stage III, Malignant Melanoma Stage IV, Melanoma, +11 more
- Locations
-
- Baylor University Medical Center Dallas, Texas, United States
NCT01264731
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- University of Virginia Charlottesville, Virginia, United States
NCT00705640
- Conditions
- Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +17 more
- Locations
-
- University of Virginia Cancer Center Charlottesville, Virginia, United States
Completed
A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)
NCT01765543
- Conditions
- Malignant Melanoma, Neoplasms, Melanoma, Neoplasms, +10 more
- Locations
-
- Rogers, Arkansas, United States
- Pleasant Hill, California, United States
- Middletown, Ohio, United States
- Dallas, Texas, United States